NO20013884L - Lipid A1-karboksylsyreanaloger av etertype - Google Patents

Lipid A1-karboksylsyreanaloger av etertype

Info

Publication number
NO20013884L
NO20013884L NO20013884A NO20013884A NO20013884L NO 20013884 L NO20013884 L NO 20013884L NO 20013884 A NO20013884 A NO 20013884A NO 20013884 A NO20013884 A NO 20013884A NO 20013884 L NO20013884 L NO 20013884L
Authority
NO
Norway
Prior art keywords
carboxylic acid
ether type
acid analogues
type lipid
lipid
Prior art date
Application number
NO20013884A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013884D0 (no
Inventor
Yukiko Kazama
Masao Shiozaki
Shinichi Kurakata
Saori Kanai
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20013884D0 publication Critical patent/NO20013884D0/no
Publication of NO20013884L publication Critical patent/NO20013884L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06Fatty acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals
    • C07H7/027Keto-aldonic acids
NO20013884A 1999-02-10 2001-08-09 Lipid A1-karboksylsyreanaloger av etertype NO20013884L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3253299 1999-02-10
PCT/JP2000/000726 WO2000047595A1 (fr) 1999-02-10 2000-02-10 Analogues de type ether d'acide a1-carboxylique lipidique

Publications (2)

Publication Number Publication Date
NO20013884D0 NO20013884D0 (no) 2001-08-09
NO20013884L true NO20013884L (no) 2001-10-09

Family

ID=12361564

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013884A NO20013884L (no) 1999-02-10 2001-08-09 Lipid A1-karboksylsyreanaloger av etertype

Country Status (18)

Country Link
US (1) US6511965B2 (ko)
EP (1) EP1152007A4 (ko)
KR (1) KR20010102018A (ko)
CN (1) CN1346361A (ko)
AU (1) AU757507B2 (ko)
BR (1) BR0008146A (ko)
CA (1) CA2362246A1 (ko)
CZ (1) CZ20012919A3 (ko)
HK (1) HK1040519A1 (ko)
HU (1) HUP0105115A3 (ko)
ID (1) ID29919A (ko)
IL (1) IL144706A0 (ko)
NO (1) NO20013884L (ko)
PL (1) PL350032A1 (ko)
TR (1) TR200102325T2 (ko)
TW (1) TW527358B (ko)
WO (1) WO2000047595A1 (ko)
ZA (1) ZA200106547B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1930180B (zh) * 2004-01-08 2010-05-26 三共株式会社 左侧葡萄糖脂a类似物
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
WO2008059307A2 (en) * 2006-11-16 2008-05-22 Om Pharma Functionalized beta 1,6 glucosamine disaccharides and process for their preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU660325B2 (en) 1991-10-11 1995-06-22 Eisai Co. Ltd. Anti-endotoxin compounds and related molecules and methods
SK281944B6 (sk) 1993-11-17 2001-09-11 Laboratoires Om S. A. Beta(1->6)glukozamínové disacharidy, spôsob ich prípravy, farmaceutický prostriedok, ktorý ich obsahuje, a ich použitie
US5681824A (en) * 1995-06-05 1997-10-28 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
WO1998042719A1 (fr) 1997-03-25 1998-10-01 Sankyo Company, Limited. Derives d'acide carboxylique avec lipides en position a1

Also Published As

Publication number Publication date
US20020161221A1 (en) 2002-10-31
TR200102325T2 (tr) 2002-08-21
ZA200106547B (en) 2002-11-08
ID29919A (id) 2001-10-25
IL144706A0 (en) 2002-06-30
KR20010102018A (ko) 2001-11-15
AU2459900A (en) 2000-08-29
EP1152007A1 (en) 2001-11-07
US6511965B2 (en) 2003-01-28
WO2000047595A1 (fr) 2000-08-17
CN1346361A (zh) 2002-04-24
BR0008146A (pt) 2002-01-15
CZ20012919A3 (cs) 2002-03-13
AU757507B2 (en) 2003-02-20
CA2362246A1 (en) 2001-08-10
NO20013884D0 (no) 2001-08-09
HUP0105115A2 (hu) 2002-04-29
TW527358B (en) 2003-04-11
PL350032A1 (en) 2002-10-21
HK1040519A1 (zh) 2002-06-14
EP1152007A4 (en) 2002-07-24
HUP0105115A3 (en) 2003-03-28

Similar Documents

Publication Publication Date Title
IS2231B (is) Nýjar amínóprópýlfosfínsýrur
ATE239005T1 (de) (4-sulfonylamino)-tetrahydropyran-4-carbonsäure hydroxamiden
EE04772B1 (et) 3-arüül-2-hüdroksüpropaanhappe derivaat (I)
PT1077957E (pt) Derivados do acido oxi-iminoalcanoico
ATE228995T1 (de) Aminomethylcarbonsäurederivate
IS5735A (is) Ný 3-arýl-2-hýdroxýprópínsýruafleiða III
ATE494366T1 (de) Lysophospholipase aus aspergillus
NO20021205L (no) Faste lipid formuleringer
DE60043730D1 (de) Arylsulfonamid-substituierte hydroxamsäure-derivate
EE200100708A (et) Asendatud fenoksüäädikhapped
HK1054038A1 (en) Substituted n-benzyl-indol-3-yl gloyoxylic acid derivatives having an antitumural effect
IS5562A (is) Nýjar díhýdroxýhexanósýru afleiður
NO20020161D0 (no) Vitamin D3-analoger
ID26379A (id) Katalis asam padat
NO307924B1 (no) FremgangsmÕte for fremstilling av en polyoksyalkylenkarboksylsyre
ATE309983T1 (de) Beta-thio-aminosäuren
EP1340740A4 (en) LIPID OF CARBOXYLIC ACID
NO20013884D0 (no) Lipid A1-karboksylsyreanaloger av etertype
AR028237A1 (es) Soluciones de acido acetilsalicilico
ATE278659T1 (de) O-desmethylvenlafaxin-ether
DK1196366T3 (da) Carbonyleringsreaktioner
NO20024114D0 (no) Nye fettsyreanaloger
SE9803619D0 (sv) Fatty acid formulation
FI4237U1 (fi) Imurilaitteisto
SE9801991D0 (sv) New 3-aryl-2-hydroxypropionic acid derivative II

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application